• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1受体蛋白在肝内胆管癌组织中的表达及其临床作用

Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues.

作者信息

Chen Ben-Dong, Zhao Wen-Chao, Dong Jian-Da, Sima Hui

机构信息

Department of Hepatobiliary Surgery, General Hospital of NingXia Medical University, Yinchuan, 750004, Ningxia, People's Republic of China.

出版信息

Mol Biol Rep. 2014 Jul;41(7):4313-20. doi: 10.1007/s11033-014-3302-7. Epub 2014 Feb 28.

DOI:10.1007/s11033-014-3302-7
PMID:24577752
Abstract

The study investigates the expression and clinical role of GLP-1R in intrahepatic cholangiocarcinoma (ICC) tissues. ICC tissue, tissue around tumour and normal liver tissue samples from 176 ICC patients were investigated for GLP-1R expression by immunohistochemistry and western blots. Expression levels were correlated to clinical variables and to the postoperative outcome. High GLP-1R expression levels were detected in tumor tissue samples. Kaplan-Meier method was used for survival analysis of patients follow-up data. Results showed that median survival time of patients with high GLP-1R positive expression in ICC tissue were 22 months. Median survival time of patients with low GLP-1R positive expression in ICC tissue were 19.8 months. There wasn't statistical difference (p = 0.332) between two groups. Immunohistochemistry semi-quantitative analysis showed that tissue differentiation is not prognostic risk factors. In patients with GLP-1R positive expression in ICC tissue, lymph node metastasis was important prognostic factors (p = 0.001). Although statistical analysis showed that GLP-1R can not be judged as a risk prognostic factors, GLP-1 might become a new target for therapy of ICC.

摘要

该研究调查了胰高血糖素样肽-1受体(GLP-1R)在肝内胆管癌(ICC)组织中的表达及临床作用。采用免疫组织化学和蛋白质印迹法,对176例ICC患者的ICC组织、肿瘤周围组织及正常肝组织样本进行GLP-1R表达情况的研究。将表达水平与临床变量及术后结果进行关联分析。在肿瘤组织样本中检测到高GLP-1R表达水平。采用Kaplan-Meier法对患者随访数据进行生存分析。结果显示,ICC组织中GLP-1R阳性高表达患者的中位生存时间为22个月。ICC组织中GLP-1R阳性低表达患者的中位生存时间为19.8个月。两组之间无统计学差异(p = 0.332)。免疫组织化学半定量分析显示,组织分化不是预后危险因素。在ICC组织中GLP-1R阳性表达的患者中,淋巴结转移是重要的预后因素(p = 0.001)。虽然统计分析显示GLP-1R不能被判定为风险预后因素,但GLP-1可能成为ICC治疗的新靶点。

相似文献

1
Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues.胰高血糖素样肽-1受体蛋白在肝内胆管癌组织中的表达及其临床作用
Mol Biol Rep. 2014 Jul;41(7):4313-20. doi: 10.1007/s11033-014-3302-7. Epub 2014 Feb 28.
2
Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.鉴定Homer1作为肝内胆管癌的潜在预后标志物。
Asian Pac J Cancer Prev. 2014;15(7):3299-304. doi: 10.7314/apjcp.2014.15.7.3299.
3
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.PRL-3 在人肝内胆管细胞癌中的表达及预后价值。
Pathol Oncol Res. 2010 Jun;16(2):169-75. doi: 10.1007/s12253-009-9200-y. Epub 2009 Sep 9.
4
Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.14-3-3ζ在肝内胆管癌中的表达上调及其临床意义
Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13.
5
A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.人肝内胆管癌细胞中高表达整合素α6 与迁移和侵袭表型相关。
Dig Dis Sci. 2013 Jun;58(6):1627-35. doi: 10.1007/s10620-012-2524-6. Epub 2013 Jan 11.
6
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.EYA4基因作为一种预后标志物发挥作用,并抑制肝内胆管癌的生长。
Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.
7
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.高迁移率族蛋白盒1在肝内胆管癌中的表达与淋巴结转移
World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.
8
The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.血管内皮生长因子-C在肝内胆管癌中表达的临床病理意义
Am J Clin Oncol. 2006 Apr;29(2):138-42. doi: 10.1097/01.coc.0000204402.29830.08.
9
High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.Dickkopf 相关蛋白 1 的高表达与肝内胆管癌患者术后的淋巴转移相关,并提示不良预后。
Cancer. 2013 Mar 1;119(5):993-1003. doi: 10.1002/cncr.27788. Epub 2012 Nov 6.
10
Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.基质LOXL2过表达对肝内胆管癌预后的影响
J Surg Res. 2016 Jun 15;203(2):441-50. doi: 10.1016/j.jss.2016.03.044. Epub 2016 Mar 26.

引用本文的文献

1
Comparison of Exendin-4 and Its Single Amino Acid Substitutions as Parent Peptides for GLP-1 Receptor Imaging Probes.艾塞那肽-4及其单氨基酸取代物作为胰高血糖素样肽-1受体成像探针的母体肽的比较。
Molecules. 2025 Feb 21;30(5):1011. doi: 10.3390/molecules30051011.
2
Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma.胰高血糖素样肽 1 受体激动剂:胆管癌潜在的变革者。
World J Gastroenterol. 2024 Sep 14;30(34):3862-3867. doi: 10.3748/wjg.v30.i34.3862.
3
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo.

本文引用的文献

1
Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection.肝内胆管细胞癌:遗传血色病对手术切除后结局和总生存率的影响。
J Surg Res. 2013 Mar;180(1):56-61. doi: 10.1016/j.jss.2012.10.051. Epub 2012 Nov 20.
2
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.原发性肝癌发病机制中是否存在共同因素?肝内胆管癌危险因素的荟萃分析。
J Hepatol. 2012 Jul;57(1):69-76. doi: 10.1016/j.jhep.2012.02.022. Epub 2012 Mar 13.
3
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
利拉鲁肽在体内外对肝内胆管癌的进展具有潜在的抗肿瘤作用。
Sci Rep. 2024 Jun 14;14(1):13726. doi: 10.1038/s41598-024-64774-2.
4
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study.二肽基肽酶-4 抑制剂与 2 型糖尿病患者胆囊和胆管疾病风险:一项基于人群的队列研究。
Drug Saf. 2024 Aug;47(8):759-769. doi: 10.1007/s40264-024-01434-4. Epub 2024 May 8.
5
Cancer biology in diabetes update: Focusing on antidiabetic drugs.糖尿病相关癌症生物学研究进展:聚焦于抗糖尿病药物。
J Diabetes Investig. 2024 May;15(5):525-540. doi: 10.1111/jdi.14152. Epub 2024 Mar 8.
6
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits.二肽基肽酶-4 抑制剂和胰高血糖素样肽-1 受体激动剂:心血管安全性和益处。
Mil Med Res. 2022 Aug 20;9(1):45. doi: 10.1186/s40779-022-00410-2.
7
The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence.胰岛素和肠促胰岛素类药物在胆管癌中的作用:流行病学及实验证据
Discov Oncol. 2022 Aug 7;13(1):70. doi: 10.1007/s12672-022-00536-8.
8
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.基于肠促胰岛素药物的使用与胆管癌风险:斯堪的纳维亚队列研究。
Diabetologia. 2021 Oct;64(10):2204-2214. doi: 10.1007/s00125-021-05508-1. Epub 2021 Jul 13.
9
CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology.CD26/二肽基肽酶-4:对癌症生物学有潜在影响的2型糖尿病药物靶点
Cancers (Basel). 2021 May 2;13(9):2191. doi: 10.3390/cancers13092191.
10
Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling.奥沙利铂通过改变FoxO1信号通路逆转GLP-1R介导的肝内胆管癌促进作用。
Oncol Lett. 2019 Aug;18(2):1989-1998. doi: 10.3892/ol.2019.10497. Epub 2019 Jun 19.
代谢综合征会增加美国原发性肝癌的风险:SEER-医疗保险数据库研究。
Hepatology. 2011 Aug;54(2):463-71. doi: 10.1002/hep.24397. Epub 2011 Jun 30.
4
Risk factors for cholangiocarcinoma.胆管癌的危险因素。
Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351.
5
Cholangiocarcinoma--controversies and challenges.胆管癌——争议与挑战。
Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200. doi: 10.1038/nrgastro.2011.20.
6
Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.病毒性肝炎与具有胆管分化和 N-钙黏蛋白表达的肝内胆管癌相关。
Mod Pathol. 2011 Jun;24(6):810-9. doi: 10.1038/modpathol.2011.41. Epub 2011 Mar 18.
7
Intrahepatic cholangiocarcinoma.肝内胆管细胞癌。
Surg Clin North Am. 2010 Aug;90(4):817-37. doi: 10.1016/j.suc.2010.04.011.
8
Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.未经手术、化疗或放疗的晚期胆管癌的自然史和预后因素:一项大规模观察性研究。
Gut Liver. 2009 Dec;3(4):298-305. doi: 10.5009/gnl.2009.3.4.298. Epub 2009 Dec 31.
9
Diabetes and risk of incident colorectal cancer in a prospective cohort of women.糖尿病与女性前瞻性队列中结直肠癌发病风险的关系。
Cancer Causes Control. 2010 Aug;21(8):1277-84. doi: 10.1007/s10552-010-9555-0. Epub 2010 Apr 10.
10
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.乙型肝炎病毒相关的肝内胆管细胞癌和肝细胞癌可能具有共同的致癌过程。
Eur J Cancer. 2010 Apr;46(6):1056-61. doi: 10.1016/j.ejca.2010.02.005. Epub 2010 Mar 4.